Medical News

RSS

Northwest Biotherapeutics raises $2.65M during second-quarter

Northwest Biotherapeutics, Inc., developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors. The funding included $1.75 million in purchases of restricted common stock of the Company by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.

7 Jul 2010

Rutgers researchers report genetic coding responsible for making QPM kernels sturdy

Rutgers researchers have discovered the basis for what makes corn kernels hard, a quality that allows corn to be easily harvested, stored and transported. The findings could lead to better hybrids and increase the supply for people in developing countries who rely on it as a nutritional staple.

7 Jul 2010

NIH awards $2.8M grant for development of diagnostic multiplex testing platform with BMB technology

Applied BioCode, Inc. and Maxwell Sensors Inc. announced today that they have received a $2.8M three-year grant from the Recovery Act Limited Competition: National Institutes of Health (NIH), for the development of a high throughput diagnostic multiplex testing platform using their Barcoded Magnetic Beads (BMB) technology for various high value immunodiagnostics and molecular diagnostic tests.

7 Jul 2010

Scientists identify potential disease genes in humans and mice

An international consortium of scientists of Helmholtz Zentrum München and the University of Toronto has identified previously unknown potential disease genes in humans and mice. Genes on the X chromosome, which regulate embryonic development, are the focus of the current publication in the renowned journal Genome Research. Men have only one X chromosome, and therefore mutations on this chromosome disproportionately affect males, frequently leading to serious diseases such as hemophilia, muscular dystrophy and mental retardation.

7 Jul 2010

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.

7 Jul 2010

Alnylam Pharmaceuticals initiates dosing in Phase I human clinical study with ALN-TTR01

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.

7 Jul 2010

DATATRAK announces private placement of 357,857 common shares to directors, management

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it privately placed 357,857 common shares at a price of approximately $0.53 per share with certain members of its Board of Directors and management team.

7 Jul 2010

USW requests oil industry to re-open pattern agreement and negotiate health, safety provisions

United Steelworkers Vice President Gary Beevers, who heads the union's oil sector, sent a request to the oil industry to re-open the National Oil Bargaining pattern agreement and negotiate health and safety provisions.

7 Jul 2010

Nile completes dosing in CD-NP Phase II study for acute decompensated heart failure

Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.

7 Jul 2010

First Edition: July 7, 2010

Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.

7 Jul 2010

McCarthy Capital leads $50M investment in Life Care Companies

McCarthy Capital Corporation recently led a $50 million investment in a privately-held company, Life Care Companies LLC. Headquartered in Des Moines, Iowa, the company does business as Life Care Services (LCS) and is a national leader in providing services to senior living communities.

7 Jul 2010

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound is a highly effective technology developed to complement mammography in women with radiologically dense breasts and other risk factors.

7 Jul 2010

Researchers to discuss connection between brown fat and obesity

Researchers from all over the world will meet at Stockholm University this weekend, July 10 and 11, to discuss for the first time the connection in adult humans between brown fat and the risk of becoming obese.

7 Jul 2010

Concord Medical files annual report for fiscal 2009 on Form 20-F

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has filed its annual report for the fiscal year ended December 31, 2009 on Form 20-F with the U.S. Securities and Exchange Commission on June 30, 2010.

7 Jul 2010

CREW calls for antitrust investigation into drug companies

Today, Citizens for Responsibility and Ethics in Washington (CREW) sent a letter to the Federal Trade Commission (FTC) asking for an antitrust investigation into drug companies that offer significant discounts to doctors for providing patients with only that company's vaccines. CREW sent its letter after learning that Sanofi Pasteur and Merck require physician healthcare groups purchasing their vaccines to enter into contracts prohibiting them from purchasing vaccines made by other companies.

7 Jul 2010

Study findings may provide insight into extreme behaviors associated with rejection

The pain and anguish of rejection by a romantic partner may be the result of activity in parts of the brain associated with motivation, reward and addiction cravings, according to a study published in the July issue of the Journal of Neurophysiology.

7 Jul 2010

Insights into complex interrelationships between heart and kidneys

Research is yielding new understanding of the interactions between the heart and the kidneys—particularly the cardiorenal syndrome, in which failure of either organ can lead to failure of the other. Recent insights into the complex interrelationships between the heart and kidneys are presented in a special symposium section of the July issue of The American Journal of Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation.

7 Jul 2010

Study: Delay in school start time significantly improves adolescent sleep, mood and behavior

A pilot study conducted in a small private high school confirms what many have been touting for years: the benefits of a delayed school start time. Judy Owens, MD, a sleep expert with Hasbro Children's Hospital, reports that a modest delay in school start time of only 30 minutes was associated with significant improvements in adolescent alertness, mood and health. Her findings are published in the July issue of the Archives of Pediatric and Adolescent Medicine.

7 Jul 2010

CME announces conference on mind-body connection in psychiatric disorders

CME LLC announces Treating the Whole Patient: The Mind-Body Connection in Psychiatric Disorders, a one-day educational conference for professionals to be held on August 14, 2010, at The Island Hotel in Newport Beach, California. Leading mental health experts Rakesh Jain, MD, MPH, Jon W. Draud, MD, MS, Vladimir Maletic, MD, and Charles Raison, MD will review the most recent developments concerning the relationship between mental and physical health conditions and explore the concept of Wellness.

7 Jul 2010

Suicide barrier fails to stop overall suicide rates: Researchers

Suicide barriers on bridges might not reduce overall suicide rates by jumping from heights, as people may change location for their suicide attempt, according to a new study published on bmj.com today.

7 Jul 2010

Medical News

Northwest Biotherapeutics raises $2.65M during second-quarter

Rutgers researchers report genetic coding responsible for making QPM kernels sturdy

NIH awards $2.8M grant for development of diagnostic multiplex testing platform with BMB technology

Scientists identify potential disease genes in humans and mice

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

Alnylam Pharmaceuticals initiates dosing in Phase I human clinical study with ALN-TTR01

DATATRAK announces private placement of 357,857 common shares to directors, management

USW requests oil industry to re-open pattern agreement and negotiate health, safety provisions

Nile completes dosing in CD-NP Phase II study for acute decompensated heart failure

First Edition: July 7, 2010

McCarthy Capital leads $50M investment in Life Care Companies

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Researchers to discuss connection between brown fat and obesity

Concord Medical files annual report for fiscal 2009 on Form 20-F

CREW calls for antitrust investigation into drug companies

Study findings may provide insight into extreme behaviors associated with rejection

Insights into complex interrelationships between heart and kidneys

Study: Delay in school start time significantly improves adolescent sleep, mood and behavior

CME announces conference on mind-body connection in psychiatric disorders

Suicide barrier fails to stop overall suicide rates: Researchers

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News